SHASUN PHARMASEUTICALS LTD
RESULTS FOR Q3 FY 2013-14
(DECEMBER,2013)
Shasun
Pharamceuticals has reported good results for the third quarter ending
December,2013.
Net sales for Q3 FY 14 has gone up well to Rs.309.38
Cr; up by 8.55% from Q2 FY 14 (Rs.285.01Cr);
and up by 20.34% from Q3 FY 13
(Rs.257.09 Cr). Thus, sales improvement is very Good.
Profit from operations for Q3 FY 14 has gone up well to Rs.23.28 Cr; up by 34.49% from Q2
FY 14 (Rs.17.31 Cr); and up by 186.35% from Q3 FY 13 (Rs.8.13 Cr). The
expenses have grown but less than proportionately compared to Sales Revenue.
Other income has come down to Rs.3.46 Cr; down by -51.94%
from Q2 FY 14 (Rs.7.20 cr); and down by -57.49%
from Q3 FY 13 (Rs.8.14 Cr).
Finance costs has gone up to Rs. 13.78 cr; up by 23.81% from Q2 FY 14 (Rs.11.13
cr; and up by 40.04% from Q3 FY 13 (Rs.9.84
Cr).
Taking
into account the downturn in other income and the upswing in finance costs, Profit before tax
has come at Rs.12.96 cr; slightly down by -3.14% from Q2 FY 14 (Rs.13.38
Cr); and up by a huge 101.56% from Q3 FY 13 (Rs.6.43 Cr).
Tax expense stands at Rs.8 lakhs compared to Rs(-)4
Lakhs in preceding Qtr and Rs.1.78 Cr in Q3 FY 13.
Net Profit stands at Rs. 13.04
Cr down by -2.25% from preceding Qtr (Rs.13.34Cr); and up by a good 58.83% from Q3 FY 13 (Rs.8.21 CR).
On
a Face Value of Rs.2, Basic EPS for Q3 stands at Rs.2.3 against Rs.2.36
in preceding Quarter and Rs.1.49 in Q3 FY 13.
The
annualized EPS works out to Rs.9.2; which yields a Price
earning Ratio of 8.7 at the current market price of around Rs.80.
RESULTS TABLE
Shasun
Pharma
|
Q3
FY 14
|
%dif
QoQ
|
Q2
FY 14
|
%Dif
YoY
|
Q3
FY 13
|
Net
sales
|
30938
|
8.55
|
28501
|
20.34
|
25709
|
Other
operating income
|
1590
|
33.95
|
1187
|
16.31
|
1367
|
Total
income from operations
|
32528
|
9.57
|
29688
|
20.14
|
27076
|
Cost
of materials
|
16409
|
6.72
|
15376
|
17.12
|
14011
|
stock-in-trade
|
94
|
-77.99
|
427
|
-3.09
|
97
|
Changes
in inventories
|
-839
|
-54.4
|
-1840
|
1298.33
|
-60
|
Employee
benefits expense
|
5853
|
8.23
|
5408
|
19.91
|
4881
|
Depreciation
|
1488
|
-0.67
|
1498
|
26.64
|
1175
|
Other
expenses
|
6890
|
2.56
|
6718
|
11.87
|
6159
|
Total
expenses
|
30200
|
8.02
|
27957
|
14.99
|
26263
|
Profit
from operations
|
2328
|
34.49
|
1731
|
186.35
|
813
|
Other
income
|
346
|
-51.94
|
720
|
-57.49
|
814
|
Finance
costs
|
1378
|
23.81
|
1113
|
40.04
|
984
|
Profit before tax
|
1296
|
-3.14
|
1338
|
101.56
|
643
|
Tax
expense
|
8
|
-300
|
-4
|
-95.51
|
178
|
Net
Profit
|
1304
|
-2.25
|
1334
|
58.83
|
821
|
Face
Value (Rs.)
|
2
|
0
|
2
|
0
|
2
|
Paid-up
equity
|
1133
|
0
|
1133
|
2.72
|
1103
|
Basic
EPS
|
2.3
|
-2.54
|
2.36
|
54.36
|
1.49
|
Public
Holding%
|
58.03
|
*
* * E
N D *
* *
No comments:
Post a Comment